Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 40 /hr
Hire Dr. Tarik R.
United Kingdom
USD 40 /hr

Freelance Editor Writer & Proofreader with 10+ years experience in translational & clinical research and development

Profile Summary
Subject Matter Expertise
Services
Writing Technical Writing, Copywriting, Newswriting, General Proofreading & Editing
Research Market Research, Feasibility Study, Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Consulting Scientific and Technical Consulting
Work Experience

Senior Research Scientist in Molecular and Cellular Cancer Pathology

The John van Great Cancer Research Centre (Nottingham Trent University)

September 2011 - August 2020

Senior Lecturer in Biochemistry

Nottingham Trent University

January 2010 - August 2011

Career Development Fellow in Neurodevelopment and Cancer

MRC Toxicology Unit

July 2006 - December 2009

Research Associate In Neurodevelopment

University of Cambridge (Hudson Institute)

October 2002 - June 2006

Education

PhD in Cancer Studies

University of Paris 7

October 1998 - September 2002

MSc in Molecular and Cellular Biology

University Paris 7

October 1996 - September 1998

Doctor of Veterinary Medicine

School of Veterinary Medicine (University of Tiaret, Algeria)

October 1991 - September 1996

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
(2019). PYK2 promotes HER2-positive breast cancer invasion . Journal of Experimental & Clinical Cancer Research.
Barbato L, Bocchetti M, Di Biase A, Regad T(2019). Cancer Stem Cells and Targeting Strategies . Cells.
(2019). Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation . Journal of experimental & clinical cancer research : CR.
Luigi Mele, Francesca Paino, Federica Papaccio, Tarik Regad, David Boocock, Paola Stiuso, Angela Lombardi, Davide Liccardo, Gabriella Aquino, Antonio Barbieri, et al.(2018). A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo . Cell Death {\&} Disease. 9. (5). Springer Nature
Jayakumar Vadakekolathu, Shaymaa Ismael Kadhim Al-Juboori, Catherine Johnson, Anne Schneider, Magdalena Elżbieta Buczek, Anna Di Biase, Alan Graham Pockley, Graham Roy Ball, Desmond George Powe, Tarik Regad(2018). {MTSS}1 and {SCAMP}1 cooperate to prevent invasion in breast cancer . Cell Death {\&} Disease. 9. (3). Springer Nature
Reham M. Balahmar, David J. Boocock, Clare Coveney, Sankalita Ray, Jayakumar Vadakekolathu, Tarik Regad, Selman Ali, Shiva Sivasubramaniam(2018). Identification and characterisation of {NANOG}{\&}{\#}x002B$\mathsemicolon$/ {OCT}-4$\less$sup$\greater$high$\less$/sup$\greater$/{SOX}2{\&}{\#}x002B$\mathsemicolon$ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines . Oncotarget. Impact Journals, {LLC}
Vadakekolathu, J., Al-Juboori, S. I. K., Johnson, C., Schneider, A., Buczek, M. E., Di Biase, A., Pockley, A. G., Ball, G. R., Powe, D. G., Regad, T.(2018). MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer . Cell Death & Disease. 9.
Reham M. Balahmar, David J. Boocock, Clare Coveney, Sankalita Ray, Jayakumar Vadakekolathu, Tarik Regad, Selman Ali, Shiva Sivasubramaniam(2018). Identification and characterisation of NANOG&#x002B;/ OCT-4<sup>high</sup>/SOX2&#x002B; doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines . Oncotarget.
Marcella La Noce, Francesca Paino, Luigi Mele, Gianpaolo Papaccio, Tarik Regad, Angela Lombardi, Federica Papaccio, Vincenzo Desiderio, Virginia Tirino(2018). {HDAC}2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for {CSCs} directed therapy . Journal of Experimental {\&} Clinical Cancer Research. 37. (1). Springer Nature
Mele, L., Paino, F., Papaccio, F., Regad, T., Boocock, D., Stiuso, P., Lombardi, A., Liccardo, D., Aquino, G., Barbieri, A., et al.(2018). A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo . Cell Death & Disease. 9.
Federica Papaccio, Francesca Paino, Tarik Regad, Gianpaolo Papaccio, Vincenzo Desiderio, Virginia Tirino(2017). Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development . {STEM} {CELLS} Translational Medicine. Wiley-Blackwell
Joshua R D Pearson, Tarik Regad(2017). Targeting cellular pathways in glioblastoma multiforme . Signal Transduction and Targeted Therapy. 2. p. 17040. Springer Nature
Tarik Regad(2017). Tissue-specific cancer stem cells: reality or a mirage? . Translational Medicine Reports. 1. (1). {PAGEPress} Publications
Tarik Regad(2017). Tissue-specific cancer stem cells: reality or a mirage? . Translational Medicine Reports. 1. (1).
Dvorkina, M., Nieddu, V., Chakelam, S., Pezzolo, A., Cantilena, S., Leite, A. P., Chayka, O., Regad, T., Pistorio, A., Sementa, A. R., et al.(2017). A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma (vol 22, pg 3398, 2016) . Clinical Cancer Research. 23. (3). p. 870.
Joshua R D Pearson, Tarik Regad(2017). Targeting cellular pathways in glioblastoma multiforme . Signal Transduction and Targeted Therapy. 2. p. 17040.
Papaccio, F., Paino, F., Regad, T., Papaccio, G., Desiderio, V., Tirino, V.(2017). Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development . Stem Cells Translational Medicine. 6. (12). p. 2115-2125.
Buczek, M.E., Miles, A.K., Green, W., Johnson, C., Boocock, D.J., Pockley, A.G., Rees, R.C., Hulman, G., Van Schalkwyk, G., Parkinson, R., et al.(2016). Cytoplasmic PML promotes TGF-?-associated epithelial-mesenchymal transition and invasion in prostate cancer . Oncogene. 35. (26). p. 3465-3475.
Buczek, M.E., Miles, A.K., Green, W., Johnson, C., Boocock, D.J., Pockley, A.G., Rees, R.C., Hulman, G., Van Schalkwyk, G., Parkinson, R., et al.(2016). Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer . Oncogene. 35. (26). p. 3465-3475.
Dvorkina, M., Nieddu, V., Chakelam, S., Pezzolo, A., Cantilena, S., Leite, A. P., Chayka, O., Regad, T., Pistorio, A., Sementa, A. R., et al.(2016). A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma . Clinical Cancer Research. 22. (13). p. 3398-3409.
Dvorkina, M., Nieddu, V., Chakelam, S., Pezzolo, A., Cantilena, S., Leite, A.P., Chayka, O., Regad, T., Pistorio, A., Sementa, A.R., et al.(2016). A promyelocytic leukemia protein-thrombospondin-2 axis and the risk of relapse in neuroblastoma . Clinical Cancer Research. 22. (13). p. 3398-3409.
Buczek, M. E., Miles, A. K., Green, W., Johnson, C., Boocock, D. J., Pockley, A. G., Rees, R. C., Hulman, G., van Schalkwyk, G., Parkinson, R., et al.(2015). Role of tumour suppressor PML in prostate cancer progression . International Journal of Molecular Medicine. 36. p. S111.
Regad, T.(2015). Targeting RTK signaling pathways in cancer . Cancers. 7. (3). p. 1758-1784.
Regad, T.(2015). Targeting RTK Signaling Pathways in Cancer . Cancers. 7. (3). p. 1758-1784.
Mathieu, M.G., Miles, A.K., Ahmad, M., Buczek, M.E., Pockley, A.G., Rees, R.C., Regad, T.(2014). The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1 . Cell Death and Disease. 5. (2).
Mathieu, M.G., Miles, A.K., Ahmad, M., Buczek, M.E., Pockley, A.G., Rees, R.C., Regad, T.(2014). The helicase HAGE prevents interferon-?-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1 . Cell Death and Disease. 5. (2).
Regad, T.(2013). Molecular and cellular pathogenesis of melanoma initiation and progression . Cellular and Molecular Life Sciences. 70. (21). p. 4055-4065.
Regad, T.(2013). Molecular and cellular pathogenesis of melanoma initiation and progression . Cellular and Molecular Life Sciences. 70. (21). p. 4055-4065.
Linley, A. J., Mathieu, M. G., Miles, A. K., Rees, R. C., McArdle, S. E. B., Regad, T.(2012). The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in Vivo . Journal of Biological Chemistry. 287. (17). p. 13633-13643.
McArdle, S. E. B., Linley, A. A. J., Mathieu, M. M. G., Miles, A. A. K., Regad, T., Rees, R. C.(2012). The helicase antigen (HAGE) promotes tumor cell proliferation via up-regulation of Ras protein signalling . Cancer Research. 72.
Linley, A.J., Mathieu, M.G., Miles, A.K., Rees, R.C., McArdle, S.E.B., Regad, T.(2012). The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo . Journal of Biological Chemistry. 287. (17). p. 13633-13643.
El Mchichi, B., Regad, T., Maroui, M.-A., Rodriguez, M.S., Aminev, A., Gerbaud, S., Escriou, N., Dianoux, L., Chelbi-Alix, M.K.(2010). SUMOylation promotes PML degradation during encephalomyocarditis virus infection . Journal of Virology. 84. (22). p. 11634-11645.
El Mchichi, Bouchra, Regad, Tarik, Maroui, Mohamed-Ali, Rodriguez, Manuel S., Aminev, Aleksey, Gerbaud, Sylvie, Escriou, Nicolas, Dianoux, Laurent, Chelbi-Alix, Mounira K.(2010). SUMOylation Promotes PML Degradation during Encephalomyocarditis Virus Infection . Journal of Virology. 84. (22). p. 11634-11645.
Regad, T., Bellodi, C., Nicotera, P., Salomoni, P.(2009). The tumor suppressor Pml regulates cell fate in the developing neocortex . Nature Neuroscience. 12. (2). p. 132-140.
Regad, Tarik, Bellodi, Cristian, Nicotera, Pierluigi, Salomoni, Paolo(2009). The tumor suppressor Pml regulates cell fate in the developing neocortex . Nature Neuroscience. 12. (2). p. 132-140.
Bouchra M’chichi, Tarik Regad, Laurent Dianoux, Yann Percherancier, Mounira K. Chelbi-Alix(2008). 239 {PML} is cleaved and degraded in {EMCV}-infected cells . Cytokine. 43. (3). p. 296. Elsevier {BV}
Bouchra M&#39;chichi, Tarik Regad, Laurent Dianoux, Yann Percherancier, Mounira K. Chelbi-Alix(2008). 239 PML is cleaved and degraded in EMCV-infected cells . Cytokine. 43. (3). p. 296.
Regad, T., Roth, M., Bredenkamp, N., Illing, N., Papalopulu, N.(2007). The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF . Nature Cell Biology. 9. (5). p. 531-540.
Regad, Tarik, Roth, Martin, Bredenkamp, Nicholas, Illing, Nicola, Papalopulu, Nancy(2007). The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF . Nature Cell Biology. 9. (5). p. 531-U87.
Regad, T., Papalopulu, N.(2005). Casein kinase I phosphorylates the forkhead transcription factor FoxG1 and promotes its nuclear localisation . Developmental Biology. 283. (2). p. 657.
Tarik Regad, Mounira K. Chelbi-Alix(2002). {PML}, un nouvel interm{\'{e}}diaire de l'effet antiviral de l'interf{\'{e}}ron . m{\'{e}}decine/sciences. 18. (1). p. 25--27. {EDP} Sciences
Regad, T, Chelbi-Alix, MK(2002). PML, a mediator of interferon-induced antiviral response . M S-Medecine Sciences. 18. (1). p. 25-27.
Blondel, D, Regad, T, Poisson, N, Pavie, B, Harper, F, Pandolfi, PP, de The, H, Chelbi-Alix, MK(2002). Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies . Oncogene. 21. (52). p. 7957-7970.
Blondel, D., Regad, T., Poisson, N., Pavie, B., Harper, F., Pandolfi, P.P., De Th&#233;, H., Chelbi-Alix, M.K.(2002). Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies . Oncogene. 21. (52). p. 7957-7970.
Regad, T., Chelbi-Alix, M.K.(2001). Role and fate of PML nuclear bodies in response to interferon and viral infections . Oncogene. 20. (49 REV. IIS. 6). p. 7274-7286.
Regad, T, Saib, A, Lallemand-Breitenbach, V, Pandolfi, PP, de The, H, Chelbi-Alix, MK(2001). PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator . Embo Journal. 20. (13). p. 3495-3505.
Regad, T., Saib, A., Lallemand-Breitenbach, V., Pandolfi, P.P., De Th&#233;, H., Chelbi-Alix, M.K.(2001). PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator . EMBO Journal. 20. (13). p. 3495-3505.
Regad, T., Chelbi-Alix, M.K.(2001). Role and fate of PML nuclear bodies in response to interferon and viral infections . Oncogene. 20. (49 REV. IIS. 6). p. 7274-7286.
BOOK
Buczek, M.E., Reeder, S.P., Regad, T.(2018). Identification and isolation of cancer stem cells using NANOG-EGFP reporter system . Methods in Molecular Biology. 1692. p. 139-148.
Buczek, M.E., Reeder, S.P., Regad, T.(2018). Identification and isolation of cancer stem cells using NANOG-EGFP reporter system . Methods in Molecular Biology. 1692. p. 139-148.
Di Biase, A., Miles, A.K., Regad, T.(2018). Generation of in vitro model of epithelial mesenchymal transition (EMT) via the expression of a cytoplasmic mutant form of promylocytic leukemia protein (PML) . Methods in Molecular Biology. 1692. p. 129-138.
Di Biase, A., Miles, A.K., Regad, T.(2018). Generation of in vitro model of epithelial mesenchymal transition (EMT) via the expression of a cytoplasmic mutant form of promylocytic leukemia protein (PML) . Methods in Molecular Biology. 1692. p. 129-138.
Buczek, M.E., Edwards, J.C., Regad, T.(2015). Prostate Cancer and Prostate Cancer Stem Cells . Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics. p. 193-212.
Buczek, M.E., Edwards, J.C., Regad, T.(2015). Prostate Cancer and Prostate Cancer Stem Cells . Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics. p. 193-212.
Regad, T., Sayers, T.J., Rees, R.C.(2015). Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics . Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics. p. 1-362.
Regad, T., Sayers, T.J., Rees, R.C.(2015). Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics . Principles of Stem Cell Biology and Cancer: Future Applications and Therapeutics. p. 1-362.